Company / Capital Expenditures
Ventyx Biosciences, Inc. Capital Expenditures History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$241.0K
FY2024
5-year range
$241.0K / $514.0K
FY2021-FY2024
Trend
-53.1%
vs FY2023
Sector context
#158 of 195
Health Care
What the data says
Ventyx Biosciences, Inc.'s capital expenditures of $241,000 is lower than 81% of companies in the Health Care sector (FY2024). Declined from $275,000 to $241,000 over the past 2 years.
Based on SEC 10-K filings.
$241,000 in FY2024 with a 3-year CAGR of -2.7%.
Declined from $275,000 to $241,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 195This company $241.0K Sector average $117.2M
▼
-99.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -2.7%, indicating a declining trend.
- In FY2024, capital expenditures decreased 53.1% year-over-year.
- Ranks #158 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $241.0K | -53.1% |
| FY2023 | $514.0K | +86.9% |
| FY2022 | $275.0K | +5.0% |
| FY2021 | $262.0K | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026